Shares of Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF – Get Free Report) rose 6.6% during mid-day trading on Friday . The stock traded as high as $0.3412 and last traded at $0.3412. Approximately 68,301 shares changed hands during trading, an increase of 2,779% from the average daily volume of 2,372 shares. The stock had previously closed at $0.32.
Algernon Pharmaceuticals Stock Performance
The stock has a 50 day moving average of $0.20 and a 200 day moving average of $0.10.
About Algernon Pharmaceuticals
Algernon Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel, small-molecule therapeutics. The company’s primary strategy centers on repurposing known compounds with established safety profiles to address unmet medical needs, particularly in the realms of pulmonary fibrosis, acute lung injury and central nervous system (CNS) disorders. By leveraging existing pharmacology data, Algernon aims to accelerate its development timelines while managing costs and risks typically associated with early-stage drug discovery.
The lead asset in Algernon’s pipeline is NP-120 (ifenprodil), an orally available small molecule being investigated for idiopathic pulmonary fibrosis (IPF).
Read More
- Five stocks we like better than Algernon Pharmaceuticals
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Receive News & Ratings for Algernon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Algernon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
